- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03297099
Robotic-Assisted Laparoscopic Versus Open Surgery for Complicated Hepatolithiasis
July 24, 2018 updated by: Shuguo Zheng, MD, Southwest Hospital, China
A Prospective Cohort Study: Robotic-Assisted Laparoscopic Versus Open Surgery for Complicated Hepatolithiasis
The indication of laparoscopic surgery is mainly for early regional type hepatolithiasis.
Open surgery is the traditional treatment method for heptolithiasis.
Da Vinci surgical robot can overcome limitations of conventional laparoscopic surgery in terms of vision and instrumentation flexibility, making the minimally invasive treatment of complex hepatolithiasis possible.
The study aimed to evaluate the safety, feasibility, and efficacy of robot assist laparoscopic surgery for the treatment of complicated hepatolithiasis by contrast of open procedures.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Robot-assisted laparoscopic operation is a safe and feasible treatment for selected patients with complicated hepatolithiasis, with an advantage over open surgery in the field of intraoperative blood loss, less hilar occlusion, lower transfusion rate, less postoperative hospital stay.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 400038
- Recruiting
- Southwest Hospital
-
Contact:
- Shuguo Zheng, Professor
- Phone Number: 0086-13508308676
- Email: shuguozh@yahoo.com.cn
-
Principal Investigator:
- Shuguo Zheng, Professor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with intrahepatic bile duct stones or hepatolithiasis.
- Liver function > Child-pugh level B, no severe biliary cirrhosis, ICG ≤ 15%, the residual liver volume and standard liver volume ratio ≥ 40%. The conditions of open hepatectomy were achieved
- Age: Between 18 to 70 years
- Combined with severe liver atrophy hypertrophy syndrome, hepatic portal transposition or hilar biliary fibrosis / stenosis
- Patients with good general condition, the conditions of open Anatomical Hepatectomy were achieved
- Other organ lesions and previous biliary tract operation is not the absolute exclusion criteria
- Written informed consent
Exclusion Criteria:
- Patients with bad general condition or important organ lesions, liver resection could not be tolerated
- Age:Younger than 18 or more than 70 years old
- Malignant tumor recurrence within one month postoperation
- Complicated case need to get emergency operation
- Contraindication of laparoscopy: Combined with complicated acute cholangitis, repeated biliary tract operation, heavy intra-abdominal adhesion, Trocar can not be placed in. Artificial pneumoperitoneum could not be tolerated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Robot-assisted Laparoscopic operation
Da Vinci surgical robot can overcome limitations of conventional laparoscopic surgery in terms of vision and instrumentation flexibility, making the minimally invasive treatment of complex hepatolithiasis possible.
|
Thirty patients with hepatolithiasis were selected and divided into robot group as described in the detailed description.
Under general anesthesia, the patient was placed in a supine 30-degree reverse Trendelengburg position with both legs separating.
The surgeon work on the console, and assist surgeon stand between legs.
Operation began with division of liver ligaments, liver mobilization, followed by intrahepatic access to the Glissonian pedicle .
A endoscopic stapler devices was used for Glissonian pedicle cutting and suture.
Liver parenchyma was divided by harmonic scalpel combined with vascular stapler.
|
|
ACTIVE_COMPARATOR: Open surgery
The indication of laparoscopic surgery is mainly for early regional type hepatolithiasis.
Open surgery is the traditional treatment method for heptolithiasis.
|
surgery group as described in the detailed description.Open surgery was performed under general anesthesia with the patient in the supine position.
Routinely, a reversed L-shape incision was performed.
Operation began with division of liver ligaments, liver mobilization, followed by intrahepatic access to the Glissonian pedicle .
A endoscopic stapler devices was used for Glissonian pedicle cutting and suture.
Liver parenchyma was divided by harmonic scalpel combined with vascular stapler.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
initial stone clearance rate
Time Frame: during the operation
|
rate of the removal of the stones from intrahepatic bile duct identified by ultrasonic or computed tomography or magnetic resonance
|
during the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative parameters
Time Frame: during the operation
|
operation time, intraoperative blood loss, rate of blood transfusion
|
during the operation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative complications
Time Frame: Duration hospitalization(an expected average of 7 days)
|
ascites, pleural effusion,cardiopulmonary insufficiency,mortality, postoperative liver function failure.
|
Duration hospitalization(an expected average of 7 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2017
Primary Completion (ANTICIPATED)
June 1, 2019
Study Completion (ANTICIPATED)
June 1, 2020
Study Registration Dates
First Submitted
September 21, 2017
First Submitted That Met QC Criteria
September 25, 2017
First Posted (ACTUAL)
September 29, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 26, 2018
Last Update Submitted That Met QC Criteria
July 24, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SWHZSG006
- zhengshuguo (Registry Identifier: zhengshuguo)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatolithiasis
-
Zhujiang HospitalNot yet recruitingHepatectomy | HepatolithiasisChina
-
Southwest Hospital, ChinaChinese PLA General Hospital; Tongji Hospital; Second Affiliated Hospital, School... and other collaboratorsUnknownHepatolithiasisChina
-
Southwest Hospital, ChinaChinese PLA General Hospital; Second Affiliated Hospital, School of Medicine...Unknown
-
The Second Hospital of Anhui Medical UniversityRecruitingLaparoscopic Liver Resection | Enhanced Recovery | Hepatolithiasis | Open Liver ResectionChina
-
Shengjing HospitalCompletedEndoscopy, Digestive System | Hepatolithiasis
-
The Second Affiliated Hospital of Chongqing Medical...CompletedHepatectomy | Liver Cancer | Hepatolithiasis | Hepatic HemangiomaChina
-
Zhejiang UniversityCompletedSphincter of Oddi Dysfunction | HepatolithiasisChina
Clinical Trials on Robot-assisted Laparoscopic operation
-
Kantonsspital AarauUnknownVaginal Vault ProlapseSwitzerland
-
Changhai HospitalUnknownNephrectomy | Robotic Surgical Procedures | ProstatectomyChina
-
RenJi HospitalUnknown
-
Ankara Training and Research HospitalNot yet recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell CancerUnited States
-
Ascher-Walsh, Charles, M.D.Completed
-
UMC UtrechtCompletedEsophageal Cancer | Esophageal CarcinomaNetherlands
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingGynecologic Cancer | Endometrial Neoplasms | Obesity, Morbid | Endometrial Cancer | Gynecologic DiseaseItaly
-
Fudan UniversityActive, not recruiting
-
University of FloridaWithdrawnVentral HerniaUnited States